Literature DB >> 29869297

The relationship between alexithymia and headache impact: the role of somatization and pain catastrophizing.

Eun-Jung Shim1, Aram Park2, Sung-Pa Park3.   

Abstract

PURPOSE: The present study compared psychological factors (i.e., alexithymia, somatization, pain catastrophizing (PC), anxiety, and depression) and QOL for headache patients and headache-free individuals, and examined whether somatization and PC mediate the relationship between alexithymia and headache impact in headache patients.
METHODS: Study participants consisted of 123 headache patients from an outpatient clinic at a university hospital and 124 headache-free individuals in Daegu, Korea. The survey employed the somatization and anxiety subscales of the Symptom Checklist-90-revised, the Patient Health Questionnaire-9, Pain Catastrophizing Scale, Toronto Alexithymia Scale, Short-Form Health survey-8 (SF-8), and the Headache Impact Test-6.
RESULTS: Headache patients showed a higher level of all psychological factors and lower level of two summary scores (physical and mental health) as well as the seven dimensions of the SF-8 compared with headache-free individuals. Examination employing the SPSS Process macro found that the direct effect of alexithymia on headache impact was not significant after controlling for somatization and PC. The total indirect effects of alexithymia on headache impact were significant without anxiety and depression as covariates with the significant indirect effects of alexithymia on headache impact via somatization or via PC as well as via somatization and PC. However, after controlling for anxiety and depression, PC was the only significant pathway through which alexithymia was related to headache impact.
CONCLUSIONS: Headache patients may benefit from interventions aiming at improving psychological factors in order to improve the functioning and QOL of headache patients.

Entities:  

Keywords:  Alexithymia; Headache impact; Migraine; Pain catastrophizing; Quality of life; Somatization; Tension-type headache

Mesh:

Year:  2018        PMID: 29869297     DOI: 10.1007/s11136-018-1894-4

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  57 in total

1.  Depression, automatic thoughts, alexithymia, and assertiveness in patients with tension-type headache.

Authors:  Basak Yücel; Kaan Kora; Süleyman Ozyalçín; Nilüfer Alçalar; Ozay Ozdemir; Aysen Yücel
Journal:  Headache       Date:  2002-03       Impact factor: 5.887

2.  Internet-based guided self-help intervention for chronic pain based on Acceptance and Commitment Therapy: a randomized controlled trial.

Authors:  Hester R Trompetter; Ernst T Bohlmeijer; Martine M Veehof; Karlein M G Schreurs
Journal:  J Behav Med       Date:  2014-06-13

3.  A randomized, controlled trial of acceptance and commitment therapy and cognitive-behavioral therapy for chronic pain.

Authors:  Julie Loebach Wetherell; Niloofar Afari; Thomas Rutledge; John T Sorrell; Jill A Stoddard; Andrew J Petkus; Brittany C Solomon; David H Lehman; Lin Liu; Ariel J Lang; J Hampton Atkinson
Journal:  Pain       Date:  2011-06-17       Impact factor: 6.961

4.  Psychiatric symptoms may contribute to poor quality of life in adolescents with migraine.

Authors:  Joelma Karin Sagica Fernandes Paschoal; Jaime Lin; Ricardo Silva Pinho; Solange Andreoni; Thais Soares Cianciarullo Minett; Maria Sylvia de Souza Vitalle; Mauro Fisberg; Mario Fernando Prieto Peres; Luiz Celso Pereira Vilanova; Marcelo Rodrigues Masruha
Journal:  Pediatr Int       Date:  2013-09-20       Impact factor: 1.524

5.  Relationships between physical symptoms, emotional distress, and pain appraisal in fibromyalgia: the moderator effect of alexithymia.

Authors:  M Pilar Martínez; Ana I Sánchez; Elena Miró; María J Lami; Germán Prados; Ana Morales
Journal:  J Psychol       Date:  2014-03-05

6.  Relationships among alexithymia and pain intensity, pain interference, and vitality in persons with neuromuscular disease: Considering the effect of negative affectivity.

Authors:  Masako Hosoi; Ivan R Molton; Mark P Jensen; Dawn M Ehde; Silvia Amtmann; Sarah O'Brien; Tatsuyuki Arimura; Chiharu Kubo
Journal:  Pain       Date:  2010-03-05       Impact factor: 7.926

7.  Time-course of attentional bias for pain-related cues in chronic daily headache sufferers.

Authors:  Christina Liossi; Daniel E Schoth; Brendan P Bradley; Karin Mogg
Journal:  Eur J Pain       Date:  2008-12-13       Impact factor: 3.931

8.  Psychological, cognitive and quality of life features in the elderly with chronic headache.

Authors:  Sureeporn Uthaikhup; Michele Sterling; Gwendolen Jull
Journal:  Gerontology       Date:  2009-08-18       Impact factor: 5.140

9.  Impact of comorbidity on headache-related disability.

Authors:  K Saunders; K Merikangas; N C P Low; M Von Korff; R C Kessler
Journal:  Neurology       Date:  2008-02-12       Impact factor: 9.910

10.  Validation of the Headache Impact Test (HIT-6™) across episodic and chronic migraine.

Authors:  Min Yang; Regina Rendas-Baum; Sepideh F Varon; Mark Kosinski
Journal:  Cephalalgia       Date:  2010-09-06       Impact factor: 6.292

View more
  3 in total

1.  Alexithymia and pain experience among patients using methadone-maintenance therapy.

Authors:  Kristen P Morie; Marc N Potenza; Mark Beitel; Lindsay M Oberleitner; Corey R Roos; Sarah W Yip; David E Oberleitner; Marina Gaeta; Declan T Barry
Journal:  Drug Alcohol Depend       Date:  2020-10-24       Impact factor: 4.492

2.  Is new daily persistent headache a fallout of somatization? An observational study.

Authors:  Ravi Uniyal; Rohit Chhirolya; Adarsh Tripathi; Prabhakar Mishra; Vimal Kumar Paliwal
Journal:  Neurol Sci       Date:  2021-05-15       Impact factor: 3.307

3.  Alexithymia and facial emotion recognition in patients with craniofacial pain and association of alexithymia with anxiety and depression: a systematic review with meta-analysis.

Authors:  Roy La Touche; Alberto García-Salgado; Ferran Cuenca-Martínez; Santiago Angulo-Díaz-Parreño; Alba Paris-Alemany; Luis Suso-Martí; Aida Herranz-Gómez
Journal:  PeerJ       Date:  2021-11-29       Impact factor: 2.984

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.